Jacques Donnez

No ORCID on file · 262 papers in corpus · active 1982-2026

Study types

  • article 160
  • review 49
  • other 22
  • letter 11
  • book-chapter 7

Condition tags

  • endometriosis 205
  • adenomyosis 35
  • infertility 34
  • dyspareunia 13
  • dysmenorrhea 12
  • endometrioma 10
  • chronic_pelvic_pain 9
  • bowel_endometriosis 5
  • bladder_endometriosis 1
article 2020
·doi:10.1097/01.aog.0000663180.46470.c9

INTRODUCTION: Linzagolix is a new, investigational, non-peptide, GnRH receptor antagonist being developed to treat endometriosis-associated pain (EAP). The EDELWEISS trial was a Phase 2b, double-blind, randomized, placebo-controlled, multic…

article 2020
·doi:10.1097/01.aog.0000663200.75027.38

INTRODUCTION: Linzagolix is a new investigational, non-peptide, oral GnRH receptor antagonist being developed to treat endometriosis-associated pain (EAP). The EDELWEISS trial was a Phase 2b, double-blind, randomized, placebo-controlled, mu…

article 2020
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.02.114
article 2019
Fertility and sterility ·doi:10.1016/j.fertnstert.2019.08.081
editorial 2019
Fertility and sterility ·doi:10.1016/j.fertnstert.2018.12.018
article 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2018.01.035
article 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2018.08.016
review 2018
Minerva ginecologica ·doi:10.23736/s0026-4784.18.04229-6

Endometriosis is a benign, estrogen-dependent gynecological disorder. It is now well established that three different forms of endometriosis can occur in the pelvic cavity, namely peritoneal endometriosis, ovarian endometriosis and deep end…

editorial 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2018.10.003
review 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.12.030
other 2018
Human Reproduction ·doi:10.1093/humrep/dex352

STUDY QUESTION: Is transplantation of cryopreserved ovarian tissue from patients with borderline ovarian tumors (BOTs) a safe procedure? SUMMARY ANSWER: BOT cells were found in frozen-thawed and xenografted ovarian tissue in 1 of 11 BOT pa…

article 2018
·doi:10.1016/s0015-0282(18)30247-4
editorial 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2018.10.002
letter 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.06.019
article 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2016.12.032
other 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2016.09.033

OBJECTIVE: To evaluate gynecological and obstetrical outcomes, as well as remaining myometrial thickness, after laparoscopic repair of a cesarean scar. DESIGN: Observational study and prospective evaluation of the remaining myometrium befo…

article 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.01.005
other 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.10.015

Deep endometriosis remains a source of controversy. A number of theories may explain its pathogenesis and many arguments support the hypothesis that genetic or epigenetic changes are a prerequisite for development of lesions into deep endom…

letter 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.01.013
review 2016
Panminerva medica

Endometriosis remains a very enigmatic and perplexing disease. The exact mechanism by which endometriosis causes infertility is still unclear. In the present paper, we will review possible mechanisms leading to subfertility or infertility i…

review 2016
Fertility and sterility ·doi:10.1016/j.fertnstert.2016.07.1075
review 2016
Expert opinion on therapeutic targets ·doi:10.1080/14728222.2017.1260548

INTRODUCTION: Endometriosis is a chronic estrogen-dependent inflammatory disease of unclear etiology that affects 15-20% of women of reproductive age. Efforts are now focusing on understanding new mechanisms involved in its physiopathology,…

article 2015
Fertility and sterility ·doi:10.1016/j.fertnstert.2015.05.011
letter 2015
Fertility and sterility ·doi:10.1016/j.fertnstert.2015.10.038
article 2014
Fertility and sterility ·doi:10.1016/j.fertnstert.2013.12.049